Associate Director - Publication Strategy and Execution - Global Scientific Communications (GSC) at Eli Lilly and Company

Cork, County Cork, Ireland

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Ability to manage a book of work and develop Scientific Disclosure (SD) strategies and plans
Skill in drawing upon information from multiple internal and external sources
Experience leading asset teams in developing SD strategic and tactical plans
Capability to collaborate, lead, and influence medical leaders across Global Medical Affairs, Global Patient Outcomes/Real World Evidence, Global Clinical Development, Preclinical Development, and commercial colleagues as appropriate
Core membership in the Launch Excellence Network and role as GSC lead in the integrated planning approach (IPA)
Ability to develop, manage, and leverage dynamic strategic plans in alignment with company-wide strategies for an asset or therapeutic area(s)
Potential to directly supervise others as assigned
Collaboration with GSC Launch Capability team and other GSC members to ensure best practices

Responsibilities

Leading the development of Scientific Disclosure Strategy
Providing balanced, objective, and accurate information to the scientific community, health care professionals, payers, and patients consistently and timely across the drug development lifecycle
Managing a book of work for Scientific Disclosure strategies and plans
Ensuring effective dissemination of scientific information through strategic and tactical plans
Serving as a core member of the Launch Excellence Network and GSC lead in the integrated planning approach (IPA)
Collaborating with internal and external stakeholders to align SD plans with overall company strategies

Skills

Publication Strategy

Scientific Communications

Medical Communications

Strategic Planning

Publication Execution

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free